Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6142147rdf:typepubmed:Citationlld:pubmed
pubmed-article:6142147lifeskim:mentionsumls-concept:C0039052lld:lifeskim
pubmed-article:6142147lifeskim:mentionsumls-concept:C1323099lld:lifeskim
pubmed-article:6142147lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:6142147lifeskim:mentionsumls-concept:C0449560lld:lifeskim
pubmed-article:6142147pubmed:issue7lld:pubmed
pubmed-article:6142147pubmed:dateCreated1984-4-26lld:pubmed
pubmed-article:6142147pubmed:abstractTextWhen Sgd 101/75 was compared with clonidine in a number of tests for CNS activity, Sgd 101/75 exhibited little activity in any test. Sgd 101/75 raised BP without affecting HR in several species of anaesthetised animals. The rise in BP was subject to tachyphylaxis, could be antagonised by alpha 1-adrenoceptor antagonists, and was obtainable in reserpinised animals. The vasopressor effect of NA was antagonised by Sgd 101/75. Thus Sgd 101/75 is a directly acting partial agonist for vascular alpha 1-adrenoceptors. On the coaxially stimulated guinea-pig ileum and field stimulated rat vas deferens, the twitch response to single pulse stimulation was reduced by NA or clonidine stimulating prejunctional alpha 2-adrenoceptors. Sgd 101/75 antagonised these inhibitory effects competitively (pA2 for antagonism of clonidine on the vas = 6.12). Sgd 101/75 acted as a specific partial agonist on the alpha 1-adrenoceptors of the guinea-pig taenia caecum that subserve relaxation of this tissue. Sgd 101/75 was a full agonist on the alpha 1-adrenoceptors of the rat anococcygeus in vitro. Phenoxybenzamine (300 pM for 30 min, followed by 20 washes over the next 30 min) reduced contractions of the anococcygeus to Sgd 101/75, but produced little inhibition of NA-induced contractions. In phenoxybenzamine-pretreated preparations, Sgd 101/75 (400 microM) did not antagonise NA (maximal effect and EC50 values not changed significantly), so it was concluded that Sgd 101/75 and NA interact with different alpha 1-adrenoceptor subtypes in this tissue. The subtype specifically activated by Sgd 101/75 was designated the alpha 1s-adrenoceptor. The mouse anococcygeus contained alpha 1s-adrenoceptors, whereas this receptor was absent from the rabbit anococcygeus.lld:pubmed
pubmed-article:6142147pubmed:languageenglld:pubmed
pubmed-article:6142147pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6142147pubmed:citationSubsetIMlld:pubmed
pubmed-article:6142147pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6142147pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6142147pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6142147pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6142147pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6142147pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6142147pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6142147pubmed:statusMEDLINElld:pubmed
pubmed-article:6142147pubmed:monthSeplld:pubmed
pubmed-article:6142147pubmed:issn0379-0355lld:pubmed
pubmed-article:6142147pubmed:authorpubmed-author:JahnUUlld:pubmed
pubmed-article:6142147pubmed:authorpubmed-author:WeetmanD FDFlld:pubmed
pubmed-article:6142147pubmed:authorpubmed-author:IsmailSSlld:pubmed
pubmed-article:6142147pubmed:authorpubmed-author:TurnerNNlld:pubmed
pubmed-article:6142147pubmed:authorpubmed-author:ThieleKKlld:pubmed
pubmed-article:6142147pubmed:authorpubmed-author:LawsonKKlld:pubmed
pubmed-article:6142147pubmed:authorpubmed-author:CoatesJJlld:pubmed
pubmed-article:6142147pubmed:authorpubmed-author:ChadwickM AMAlld:pubmed
pubmed-article:6142147pubmed:issnTypePrintlld:pubmed
pubmed-article:6142147pubmed:volume5lld:pubmed
pubmed-article:6142147pubmed:ownerNLMlld:pubmed
pubmed-article:6142147pubmed:authorsCompleteYlld:pubmed
pubmed-article:6142147pubmed:pagination425-34lld:pubmed
pubmed-article:6142147pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:meshHeadingpubmed-meshheading:6142147-...lld:pubmed
pubmed-article:6142147pubmed:year1983lld:pubmed
pubmed-article:6142147pubmed:articleTitleSgd 101/75: a sympathomimetic that can be used to identify a new subtype of alpha-adrenoceptor, the alpha 1s-adrenoceptor.lld:pubmed
pubmed-article:6142147pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6142147pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6142147pubmed:publicationTypeReviewlld:pubmed